Skip to main content

Jennifer Ann Rothman

Professor of Pediatrics
Pediatrics, Hematology-Oncology
385 Hanes House, Box 102382, Durham, NC 27710

Overview


Sickle Cell Disease
Bone Marrow Failure Syndromes
General Hematology

Current Appointments & Affiliations


Professor of Pediatrics · 2022 - Present Pediatrics, Hematology-Oncology, Pediatrics
Professor in Medicine · 2022 - Present Medicine, Hematology, Medicine

Recent Publications


Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: Phase 2 ESCALATE trial.

Journal Article Blood Adv · May 2, 2025 Severe aplastic anemia (SAA) is a rare, life-threatening disease with acquired pancytopenia and hypocellular bone marrow. ESCALATE evaluated eltrombopag in combination with immunosuppressive therapy (IST) in pediatric patients (aged 1 to <18 years) with re ... Full text Link to item Cite

Multicenter comparative study of polysomnography outcomes in children with the monogenic disorder sickle cell disease.

Journal Article J Clin Sleep Med · February 1, 2025 STUDY OBJECTIVES: Sleep-disordered breathing is prevalent in children with sickle cell disease (SCD) and is associated with worse outcomes. This study aimed to compare the outcomes of polysomnography (PSG) performed for pediatric patients with SCD at 3 US ... Full text Link to item Cite
View All Publications

Recent Grants


Achieving Understanding of the Natural history of sickle cell Trait (AUNT)

ResearchCollaborating Investigator · Awarded by National Alliance for Sickle Cell Centers · 2024 - 2026

A Phase 3 Study of Eltrombopag vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2019 - 2026

View All Grants

Education, Training & Certifications


University of Medicine and Dentistry of New Jersey · 2003 M.D.